Discover a study showing barzolvolimab rapidly improves chronic spontaneous urticaria symptoms, offering hope for patients ...

According to the CDC, an estimated 1 in 13 children have food allergies. And at least 2 in 5 children, or 40 percent, have ...

Treatment for chronic hives lasting at least 6 weeks may include one or more types of medication, as well as certain ...

First large, randomized, placebo-controlled study to demonstrate clinical benefit in patients with Cold Urticaria (ColdU) and Symptomatic ...

In a safety-net hospital lacking allergy/immunology services, most patients with urticaria do not receive ...

Chronic urticaria affects 17% of patients, with higher age, elevated BMI, and early prednisolone use as key determinants of prolonged disease duration. The study utilized data from the Julius General ...

Dr S. Shahzad Mustafa looks ahead to ACAAI 2025, which will highlight advances in chronic urticaria treatment and ...

Alys Pharmaceuticals has announced the dosing of the first subject in its phase 1/1b trial of ALY-301, a first-in-class mast ...

Individuals diagnosed with chronic spontaneous urticaria (CSU) are at a moderately increased risk of multiple cardiovascular ...

Detailed price information for Beone Medicines Ltd (ONC-Q) from The Globe and Mail including charting and trades.

Barzolvolimab treatment demonstrated rapid and profound improvement in urticaria control with sustained efficacy, including after the completion of active therapy, in patients with CSU refractory to ...

How one woman went from a severe alopecia areata diagnosis to finding the right prescription treatment for her—and getting ...